Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression.
2 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.
The 2 matches
- [1] § Results › Integrative multi-omics validation pinpoints key proteins ↔ run_scRNA_DEA.R, lines 1 to 43 · score 0.77 · oligodendrocyte precursor cell, endothelial cells, single cell, RNA, astrocyte, neuron · block
oscr:b:M65WM8AGWSM2E-P· Report a mismatch - [2] § Methods › Statistical analysis › Validating proteins using causal evidence from MR ↔ run_MR.R, lines 54 to 119 · score 0.57 · Wald ratio, error, IVW, MR, exposure, R2 · block
oscr:b:SV8C70Z6P71NA-I· Report a mismatch
Paper
Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
R · 112 lines · 2.8 KB · no license · 1 match
- #!/usr/bin/env Rscript
- suppressPackageStartupMessages({
- library(Seurat)
- library(data.table)
- })
- # =========================
- # Inputs (edit here)
- # =========================
- seurat_rds <- "data/scRNA/ms_single_cell.rds"
- outdir <- "results/scRNA_DE"
- # cell types to keep (edit to your study)
- cell_types_to_keep <- c(
- "microglial cell",
- "oligodendrocyte",
- "oligodendrocyte precursor cell",
- "astrocyte",
- "endothelial cell",
- "neuron",
- "pericyte",
- "progenitor cell"
- )
- # target genes (Ensembl IDs in your example)
- target_genes <- c(
- "ENSG00000197959", # DNM3 (example)
- "ENSG00000075292", # ZNF638
- "ENSG00000174227", # PIGG
- "ENSG00000135636" # DYSF
- )
- # disease labels in metadata
- group_var <- "disease"
- case_level <- "multiple sclerosis"
- ctrl_level <- "normal"
- # FindMarkers settings (minimal & robust)
- min_pct <- 0.1
- test_use <- "wilcox"
- dir.create(outdir, recursive = TRUE, showWarnings = FALSE)
- # =========================
- # Load Seurat object
- # =========================
- obj <- readRDS(seurat_rds)
- # Required metadata checks
- meta_cols <- colnames([email hidden])
- stopifnot("cell_type" %in% meta_cols)
- stopifnot(group_var %in% meta_cols)
- # Subset cell types of interest
- obj <- subset(obj, subset = cell_type %in% cell_types_to_keep)
- # Keep only target genes present in object
- target_present <- intersect(target_genes, rownames(obj))
- if (length(target_present) == 0) {
- stop("None of target_genes found in Seurat object rownames().")
- }
- # =========================
- # Differential expression per cell type
- # =========================
- res_list <- list()
- for (ct in cell_types_to_keep) {
- sub <- subset(obj, subset = cell_type == ct)
- # check both groups exist
- groups <- unique(as.character([email hidden][[group_var]]))
- if (!(case_level %in% groups && ctrl_level %in% groups)) {
- message("[SKIP] ", ct, ": missing one of groups (", ctrl_level, ", ", case_level, ")")
- next
- }
- # run DE only on target genes (fast + focused)
- mk <- FindMarkers(
- object = sub,
- group.by = group_var,
- ident.1 = case_level,
- ident.2 = ctrl_level,
- features = target_present,
- logfc.threshold = 0,
- min.pct = min_pct,
- test.use = test_use
- )
- if (nrow(mk) == 0) next
- mk$gene <- rownames(mk)
- mk$cell_type <- ct
- # FDR
- mk$p_val_adj_fdr <- p.adjust(mk$p_val, method = "fdr")
- res_list[[ct]] <- mk
- }
- res <- data.table::rbindlist(res_list, fill = TRUE)
- # Save
- data.table::fwrite(res, file.path(outdir, "MS_vs_normal_DE_target_genes.tsv"), sep = "\t")
- # Also save significant results only
- res_sig <- res[p_val_adj_fdr < 0.05]
- data.table::fwrite(res_sig, file.path(outdir, "MS_vs_normal_DE_target_genes_sig.tsv"), sep = "\t")
- message("[DONE] Wrote results to: ", outdir)
run_scRNA_DEA.R at commit d2cb5ff, no license · at the source
Overview
- Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77 Sweden
- Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 610041 Chengdu, China
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177 Sweden
Abstract
Introduction: Current therapies for multiple sclerosis (MS) primarily reduce relapse rates and delay disability by targeting inflammation, while have limited efficacy against disease progression driven by neurodegenerative processes. We sought to identify and validate proteins for MS progression by integrating a large genome-wide association study (GWAS) of MS progression with large-scale protein quantitative trait loci data from blood and brain.
Methods: We conducted proteome-wide association studies (PWAS) to nominate proteins; applied summary-data Mendelian randomization and colocalization to evaluate association; and performed functional annotation (pathway enrichment, drug-target mapping, and protein-protein interaction networks) to prioritize therapeutic potential. Additionally, we performed external validation through bulk and cell-type-specific expression analyses and prioritized protein evaluation. The final key proteins were determined by triangulating evidence across all these streams.
Results: We identified 48 genetically prioritized proteins. Functional annotation prioritized 14 with therapeutic potential and highlighted 13 non-MS drugs for repurposing. Triangulation of evidence with multi-omics external validation highlighted six key proteins: RRM2B (a Cladribine target), CBR1, and ETFA, which are linked to existing drugs; DNM3 (a GWAS-implicated locus), CAB39L, and NMRAL1, which emerged as validated novel proteins providing biological insight into MS progression.
Conclusion: Our multi-omics integration prioritizes proteins implicated in MS progression, providing mechanistic insights into neurodegeneration and a foundation for future therapeutic exploration in progressive MS.
Supplementary Information: The online version contains supplementary material available at 10.1186/
Reproduced under the paper's license (CC BY), from the paper cited above.
Repository
Its files are read in the Code ↔ Paper reader above, with 2 matches between paragraphs and lines of code.
Yuanjiang1110/MS-progression-drug-targets
d2cb5ff554886c9155b88c851c89cc742426c410, 4 March 2026Availability: 1 check, the latest on 27 September 2026: the link answers
- 27 September 2026: the link answers
7 files
- run_MR.R, R, 145 lines, 1 match
- run_PWAS.bash, Shell, 16 lines
- run_SMR.bash, Shell, 16 lines
- run_TWAS.bash, Shell, 16 lines
- run_coloc.R, R, 117 lines
- run_scRNA_DEA.R, R, 112 lines, 1 match
- README.md, Text, 13 lines
Code availability
The R scripts and analytical pipelines used to generate the results of this study are available on GitHub at: [https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 6 scripts, each with its path and the digest of its content;
- 2 matches between paragraphs of the paper and lines of the code (method lexical-v1);
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Datasets cited
- figshare:32656347, at figshare; found in DataCite
Data availability
All the genetic and QTL data used in this study were from the publicly accessible summary statistics and can be accessed through the corresponding references presented in the main text.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 4 keywords, 6 MeSH terms, 1 funder, 51 references.
Cite
This paper
Jiang, Y., Xiao, J., Kockum, I., Stridh, P., Liu, Q., Olsson, T., Alfredsson, L., & Jiang, X. (2026). Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. Journal of neuroinflammation, 23(1), 198. https://
BibTeX
@article{jiang2026multi,
author = {Jiang, Yuan and Xiao, Jinyu and Kockum, Ingrid and Stridh, Pernilla and Liu, Qianwen and Olsson, Tomas and Alfredsson, Lars and Jiang, Xia},
title = {{Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression}},
journal = {Journal of neuroinflammation},
year = {2026},
month = jun,
volume = {23},
number = {1},
pages = {198},
publisher = {BMC},
issn = {1742-2094},
doi = {10.1186/
url = {https://
pmid = {42231304},
pmcid = {PMC13261964}
}
RIS
TY - JOUR
AU - Jiang, Yuan
AU - Xiao, Jinyu
AU - Kockum, Ingrid
AU - Stridh, Pernilla
AU - Liu, Qianwen
AU - Olsson, Tomas
AU - Alfredsson, Lars
AU - Jiang, Xia
TI - Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression
T2 - Journal of neuroinflammation
J2 - J Neuroinflammation
PY - 2026
DA - 2026/
VL - 23
IS - 1
SP - 198
SN - 1742-2094
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression",
"container-title": "Journal of neuroinflammation",
"author": [
{
"family": "Jiang",
"given": "Yuan"
},
{
"family": "Xiao",
"given": "Jinyu"
},
{
"family": "Kockum",
"given": "Ingrid"
},
{
"family": "Stridh",
"given": "Pernilla"
},
{
"family": "Liu",
"given": "Qianwen"
},
{
"family": "Olsson",
"given": "Tomas"
},
{
"family": "Alfredsson",
"given": "Lars"
},
{
"family": "Jiang",
"given": "Xia"
}
],
"container-title-short":
"volume": "23",
"issue": "1",
"page": "198",
"DOI": "10.1186/
"PMID": "42231304",
"PMCID": "PMC13261964",
"ISSN": "1742-2094",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
2
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/ijms27167275 [code]
- Integrative Multi-Omics Analysis of Multiple Sclerosis Reveals Cell-Type-Specific Regulatory Landscapes and Discordant Methylation-Expression Coupling.Journal: International journal of molecular sciencesIn common: data.table, multiple sclerosis, genetics / omics, cellular / molecular, 5 references
- [2] doi:10.1038/s41467-024-50794-z [code]
- A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis.Journal: Nature communicationsIn common: multiple sclerosis, genetics / omics, cellular / molecular, 1 reference, author Ingrid Kockum
- [3] doi:10.1371/journal.pcbi.1014422 [code]
- Deciphering cell type-specific causal genetic effects on brain imaging-derived phenotypes and disorders with single-cell Mendelian randomization.Journal: PLoS computational biologyIn common: data.table, genetics / omics, cellular / molecular, 4 references
- [4] doi:10.1038/s41467-025-63371-9 [code]
- Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids.Journal: Nature communicationsIn common: Seurat, data.table, multiple sclerosis, genetics / omics, cellular / molecular, 2 references
- [5] doi:10.1212/nxi.0000000000200213 [code]
- Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.Journal: Neurology(R) neuroimmunology & neuroinflammationIn common: Seurat, data.table, multiple sclerosis, genetics / omics, cellular / molecular, 2 references
- [6] doi:10.3389/fbinf.2026.1832826 [code]
- Spatial transcriptomics reveal heterogeneous cell‒cell interactions among brain regions in cuprizone model consistent with multiple sclerosis lesions.Journal: Frontiers in bioinformaticsIn common: Seurat, multiple sclerosis, genetics / omics, cellular / molecular, 3 references
- [7] doi:10.1016/j.ebiom.2023.104631 [code]
- Dilated Virchow-Robin spaces are a marker for arterial disease in multiple sclerosis.Journal: EBioMedicineIn common: multiple sclerosis, author Ingrid Kockum
- [8] doi:10.1093/braincomms/fcaf152 [code]
- Brain age in multiple sclerosis: a study with deep learning and traditional machine learning.Journal: Brain communicationsIn common: multiple sclerosis, author Ingrid Kockum
- [9] doi:10.1038/s41588-024-02050-9 [code]
- Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes.Journal: Nature geneticsIn common: Seurat, data.table, genetics / omics, cellular / molecular, 2 references
- [10] doi:10.1038/s41588-025-02291-2 [code]
- Multiancestry brain pQTL fine-mapping and integration with genome-wide association studies of 21 neurologic and psychiatric conditions.Journal: Nature geneticsIn common: genetics / omics, cellular / molecular, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 6 scripts, and 2 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:357f42213a432542…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z.svg
:target: https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z"><img src="https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".
If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
